Groups | CRP(mg/L) | WBC(109/L) | IgE(g/L) | IgG(g/L) | IL-6(pg/mL) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
Study group (n = 108) | 48.01 ± 11.67 | 8.37 ± 2.28 | 9.95 ± 3.3 | 7.73 ± 2.0 | 9.51 ± 1.84 | 2.41 ± 1.57 | 7.69 ± 0.88 | 12.67 ± 1.12* | 39.57 ± 5.73 | 12.35 ± 2.03* |
Control group (n = 172) | 47.72 ± 12.08 | 11.19 ± 3.49 | 9.38 ± 2.88 | 6.61 ± 1.22 | 9.78 ± 1.91 | 3.19 ± 1.47 | 7.54 ± 0.91 | 9.59 ± 1.94 | 40.06 ± 5.86 | 19.78 ± 1.96 |
t | 0.198 | 7.510 | 1.557 | 5.869 | 1.196 | 4.302 | 1.434 | 15.301 | 0.685 | 31.027 |
P | 0.843 | < 0.001 | 0.121 | < 0.001 | 0.233 | < 0.001 | 0.153 | < 0.001 | 0.494 | < 0.001 |